Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

40.34
Delayed Data
As of 4:02pm ET
 +0.66 / +1.66%
Today’s Change
39.04
Today|||52-Week Range
54.73
-10.91%
Year-to-Date
Stocks Reach Their 3-Year Lows
Mar 25 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close39.68
Today’s open40.01
Day’s range39.93 - 40.37
Volume220,273
Average volume (3 months)286,433
Market cap$6.8B
Dividend yield0.74%
Data as of 4:02pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+18.78%
Revenue growth (last year)-2.51%
P/E ratio0.7
Price/Sales3.28
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.45+0.32%
JAZZJazz Pharmaceuticals...+3.84+2.68%
TSROTESARO Inc-3.27-2.04%
IONSIonis Pharmaceutical...+0.91+2.33%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)$0.41
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts


Search for Jobs